ARTICLE | Clinical News
ARG201 regulatory update
February 23, 2009 8:00 AM UTC
EMEA granted Orphan Drug designation for arGentis' ARG201 to treat diffuse systemic sclerosis. The type I native bovine collagen, which also has Orphan designation in the U.S., has completed a Phase ...